PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma
PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinomaPBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma, Published online: 18 February 2019; doi:10.1038/s41419-019-1415-6PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma
Source: Cell death and disease - Category: Internal Medicine Authors: Hanlin Ma Yingwei Li Xiangxiang Wang Huan Wu Gonghua Qi Rongrong Li Ning Yang Min Gao Shi Yan Cunzhong Yuan Beihua Kong Source Type: research
More News: Cancer & Oncology | Carcinoma | Internal Medicine | Ovarian Cancer | Ovaries | Serous Carcinoma